DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
1496
AVOBENZONE; ECAMSULE; OCTOCRYLENE
4
Combination
Approved
OTHER
TOPICAL
Unknown
Unknown
AVOBENZONE; ECAMSULE; OCTOCRYLENE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
AVOBENZONE; ECAMSULE; OCTOCRYLENE; TITANIUM DIOXIDE
4
Combination
Approved
OTHER
TOPICAL
Unknown
Unknown
AVOBENZONE; ECAMSULE; OCTOCRYLENE; TITANIUM DIOXIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
AVOBENZONE; OCTINOXATE; OXYBENZONE
4
Combination
Approved
OTHER
TOPICAL
Unknown
Unknown
AVOBENZONE; OCTINOXATE; OXYBENZONE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
AZATADINE MALEATE; PSEUDOEPHEDRINE SULFATE
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
AZATADINE MALEATE; PSEUDOEPHEDRINE SULFATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
AZILSARTAN KAMEDOXOMIL; CHLORTHALIDONE
4
Combination
Approved
CARDIOVASCULAR; OTHER
ORAL
Unknown
Unknown
AZILSARTAN KAMEDOXOMIL; CHLORTHALIDONE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
AZITHROMYCIN DIHYDRATE; TROVAFLOXACIN MESYLATE
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
AZITHROMYCIN DIHYDRATE; TROVAFLOXACIN MESYLATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BACITRACIN; HYDROCORTISONE ACETATE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE
4
Combination
Approved
OTHER
OPHTHALMIC
Unknown
Unknown
BACITRACIN; HYDROCORTISONE ACETATE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BACITRACIN; NEOMYCIN SULFATE; POLYMYXIN B SULFATE
4
Combination
Approved
OTHER
OPHTHALMIC
Unknown
Unknown
BACITRACIN; NEOMYCIN SULFATE; POLYMYXIN B SULFATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BACITRACIN; POLYMYXIN B SULFATE
4
Combination
Approved
OTHER
TOPICAL
Unknown
Unknown
BACITRACIN; POLYMYXIN B SULFATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BACITRACIN ZINC; HYDROCORTISONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE
4
Combination
Approved
OTHER
OPHTHALMIC; TOPICAL
Unknown
Unknown
BACITRACIN ZINC; HYDROCORTISONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BACITRACIN ZINC; LIDOCAINE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE
4
Combination
Approved
OTHER
TOPICAL
Unknown
Unknown
BACITRACIN ZINC; LIDOCAINE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE
4
Combination
Approved
OTHER
OPHTHALMIC; TOPICAL
Unknown
Unknown
BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BACITRACIN ZINC; POLYMYXIN B SULFATE
4
Combination
Approved
OTHER
OPHTHALMIC; TOPICAL
Unknown
Unknown
BACITRACIN ZINC; POLYMYXIN B SULFATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BECLOMETHASONE DIPROPIONATE MONOHYDRATE
4
Small molecule
Approved
OTHER
NASAL
Unknown
Unknown
BECLOMETHASONE DIPROPIONATE MONOHYDRATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BENAZEPRIL HYDROCHLORIDE; HYDROCHLOROTHIAZIDE
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
BENAZEPRIL HYDROCHLORIDE; HYDROCHLOROTHIAZIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BENDROFLUMETHIAZIDE; NADOLOL
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
BENDROFLUMETHIAZIDE; NADOLOL
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE
4
Combination
Approved
OTHER
TOPICAL
Unknown
Unknown
BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BENZOYL PEROXIDE; ERYTHROMYCIN
4
Combination
Approved
DERMATOLOGY; OTHER
TOPICAL
Unknown
Unknown
BENZOYL PEROXIDE; ERYTHROMYCIN
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BETA CAROTENE
4
Small molecule
Approved
OTHER
ORAL
Myocardial Infarction; Myocardial Ischemia; Cataract; Crohn Disease; Macular Degeneration
Unknown
BETA CAROTENE
×
Maximum Phase:
4
First Approval:
None
UNII:
01YAE03M7J
Molecule Type:
Small molecule
Molecular Formula:
C40H56
Molecular Weight:
536.89
AlogP:
12.61
PSA:
0.0
HBD:
0.0
HBA:
#RotB:
10.0
Source:
BETAMETHASONE ACETATE; BETAMETHASONE SODIUM PHOSPHATE
4
Combination
Approved
OTHER
INJECTION
Unknown
Unknown
BETAMETHASONE ACETATE; BETAMETHASONE SODIUM PHOSPHATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BETAMETHASONE DIPROPIONATE; CALCIPOTRIENE HYDRATE
4
Combination
Approved
OTHER
TOPICAL
Unknown
Unknown
BETAMETHASONE DIPROPIONATE; CALCIPOTRIENE HYDRATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BETAMETHASONE DIPROPIONATE; CLOTRIMAZOLE
4
Combination
Approved
IMMUNE SYSTEM; OTHER
TOPICAL
Unknown
Unknown
BETAMETHASONE DIPROPIONATE; CLOTRIMAZOLE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BETAXOLOL HYDROCHLORIDE; CHLORTHALIDONE
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
BETAXOLOL HYDROCHLORIDE; CHLORTHALIDONE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BETAXOLOL HYDROCHLORIDE; PILOCARPINE HYDROCHLORIDE
4
Combination
Approved
OTHER
OPHTHALMIC
Unknown
Unknown
BETAXOLOL HYDROCHLORIDE; PILOCARPINE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BISACODYL; POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
BISACODYL; POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BISMUTH SUBCITRATE POTASSIUM; METRONIDAZOLE; TETRACYCLINE
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
BISMUTH SUBCITRATE POTASSIUM; METRONIDAZOLE; TETRACYCLINE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BISMUTH SUBSALICYLATE; METRONIDAZOLE; TETRACYCLINE HYDROCHLORIDE
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
BISMUTH SUBSALICYLATE; METRONIDAZOLE; TETRACYCLINE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BISOPROLOL FUMARATE; HYDROCHLOROTHIAZIDE
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
BISOPROLOL FUMARATE; HYDROCHLOROTHIAZIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BOSUTINIB MONOHYDRATE
4
Small molecule
Approved
CANCER; HEMATOLOGY; OTHER
ORAL
Unknown
Unknown
BOSUTINIB MONOHYDRATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BRIMONIDINE TARTRATE; BRINZOLAMIDE
4
Combination
Approved
OTHER
OPHTHALMIC
Unknown
Unknown
BRIMONIDINE TARTRATE; BRINZOLAMIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BRIMONIDINE TARTRATE; TIMOLOL MALEATE
4
Combination
Approved
OTHER
OPHTHALMIC
Unknown
Unknown
BRIMONIDINE TARTRATE; TIMOLOL MALEATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BROMODIPHENHYDRAMINE HYDROCHLORIDE; CODEINE PHOSPHATE
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
BROMODIPHENHYDRAMINE HYDROCHLORIDE; CODEINE PHOSPHATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BROMPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PSEUDOEPHEDRINE HYDROCHLORIDE
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
BROMPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PSEUDOEPHEDRINE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BROMPHENIRAMINE MALEATE; PSEUDOEPHEDRINE HYDROCHLORIDE
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
BROMPHENIRAMINE MALEATE; PSEUDOEPHEDRINE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BUDESONIDE; FORMOTEROL FUMARATE DIHYDRATE
4
Combination
Approved
OTHER
INHALATION
Unknown
Unknown
BUDESONIDE; FORMOTEROL FUMARATE DIHYDRATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
1
2
…
27
28
29
30
31
32
33
…
42
43
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA